Mobile Cardiac Telemetry Systems Market Size, Share, Growth Analysis, By Product (Multiple Lead, Mobile Cardiac Telemetry Patch), By Disease Indication (Cardiovascular Diseases, Angina Pectoris), By Region - Industry Forecast 2025-2032

Mobile Cardiac Telemetry Systems Market size was valued at USD 930.43 Million in 2023 and is poised to grow from USD 1043.01 Million in 2024 to USD 2600.96 Million by 2032, growing at a CAGR of 12.1% during the forecast period (2025-2032).

Mobile cardiac telemetry (MCAT) is an innovative and real-time cardiac monitoring technology that offers convenient and reliable monitoring of patients with cardiac diseases. These advanced devices automatically detect and transmit ECG rhythms without requiring patient participation to a distant diagnostic monitoring laboratory, enabling continuous monitoring for up to 30 days. The growing mortality rates attributed to the high prevalence of cardiovascular disorders in the population are significant drivers for the expansion of the mobile cardiac telemetry (MCAT) market. Unhealthy lifestyle choices, including physical inactivity, obesity, and smoking, contribute to increased cardiac disorder incidences. Moreover, MCAT devices are increasingly being used to rapidly detect arrhythmogenic risks in COVID-19 patients during outpatient care, fueling market growth. Technological advancements and increased investments in the development and manufacturing of these devices, coupled with their widespread utilization for remote patient monitoring to reduce hospitalizations, are further propelling the mobile cardiac telemetry (MCAT) market. Additionally, factors such as global population growth, heightened awareness about diseases and treatments, high mortality rates, increased healthcare expenditure, and rising disposable incomes are positively impacting the demand for MCAT solutions.

US Mobile Cardiac Telemetry Systems Market is poised to grow at a sustainable CAGR for the next forecast year.